This article has Open Peer Review reports available.
Anti-hepatitis B virus (HBV) response of imiquimod based toll like receptor 7 ligand in hbv-positive human hepatocelluar carcinoma cell line
- Dipanwita Das1,
- Isha Sengupta†2,
- Neelakshi Sarkar†1,
- Ananya Pal1,
- Debraj Saha1,
- Manikankana Bandopadhyay1,
- Chandrima Das2,
- Jimmy Narayan3,
- Shivaram Prasad Singh3, 4,
- Sekhar Chakrabarti1, 5 and
- Runu Chakravarty1Email author
© The Author(s). 2017
Received: 7 April 2016
Accepted: 5 January 2017
Published: 14 January 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|7 Apr 2016||Submitted||Original manuscript|
|28 Jul 2016||Reviewed||Reviewer Report - Adam J. Gehring|
|18 Aug 2016||Reviewed||Reviewer Report - K Alagarasu|
|14 Oct 2016||Author responded||Author comments - Dipanwita Das|
|Resubmission - Version 2|
|14 Oct 2016||Submitted||Manuscript version 2|
|20 Dec 2016||Author responded||Author comments - Dipanwita Das|
|Resubmission - Version 3|
|20 Dec 2016||Submitted||Manuscript version 3|
|5 Jan 2017||Editorially accepted|
|14 Jan 2017||Article published||10.1186/s12879-017-2189-z|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.